المؤلفون: Paul G.H. Mulder, Jan L. van der Zwan, Petra M.C. Callenbach, Rob H. J. M. Gooskens, Oebele F. Brouwer, Lise P. M. Pels, Wirn H. J. P. Linssen

المساهمون: Epidemiology

المصدر: European Journal of Paediatric Neurology, 11(6), 325-330. W.B. Saunders

مصطلحات موضوعية: Pediatrics, medicine.medical_specialty, Sumatriptan nasal spray, Sumatriptan Nasal Spray, Acute migraine, Adolescent, Aura, placebo-controlled studies, Migraine Disorders, ZOLMITRIPTAN, MULTICENTER, Zolmitriptan, Triptans, law.invention, DOUBLE-BLIND, children, HEADACHE, Randomized controlled trial, law, IBUPROFEN, medicine, Humans, migraine, adolescents, Child, Administration, Intranasal, Clinical Trials as Topic, business.industry, Sumatriptan, General Medicine, OPEN-LABEL, medicine.disease, RANDOMIZED-TRIAL, Serotonin Receptor Agonists, Migraine, Tolerability, Anesthesia, Child, Preschool, Pediatrics, Perinatology and Child Health, TOLERABILITY, RIZATRIPTAN 5 MG, Neurology (clinical), business, ATTACKS, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed311280e0f821fc74d03f35acdaa2af
https://pure.eur.nl/en/publications/1fee30a1-8b2e-426f-b325-25a8c364dc2c